AMA counts to 10 before voting drug shortages position

Unlike the many individual patients who report feeling powerless when they are unable to get drugs they need, doctors are plying their strength in numbers under the banner of the American Medical Association to catalyze a solution. They've voted their support for FDA and Congress to require contingency production plans of the makers of medically necessary drugs to ensure continuous supply. And members agreed to support financial incentives for drugmakers to continue production of scarce medicines, but only after ruling out the idea of financial penalties for those that don't promptly attempt to rectify shortages. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.